What is the appropriate management for a 22‑week pregnant woman with a hemoglobin level of 9.8 g/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Anemia at 22 Weeks Gestation with Hemoglobin 9.8 g/dL

This pregnant woman requires oral iron supplementation at 60-120 mg of elemental iron daily, as her hemoglobin of 9.8 g/dL meets the diagnostic threshold for anemia in pregnancy (Hb <11 g/dL in the second trimester). 1, 2

Diagnostic Confirmation

  • Hemoglobin 9.8 g/dL confirms anemia in pregnancy, as the diagnostic cutoff is <11 g/dL across all trimesters 2
  • Obtain a complete blood count (CBC) with red cell indices to characterize the anemia type 2
  • Check serum ferritin, iron studies, and transferrin saturation to confirm iron deficiency as the etiology 1
  • Screen for other causes: folate and B12 levels, hemoglobinopathy screening if not previously done, and consider parasitic infections (malaria, helminths) in endemic areas 2

Treatment Algorithm

First-Line: Oral Iron Therapy

Prescribe 60-120 mg of elemental iron daily as the standard treatment dose for iron deficiency anemia in pregnancy 1. This is substantially higher than the 30 mg daily dose used for routine supplementation in early pregnancy 1.

  • Continue treatment throughout pregnancy and reassess hemoglobin levels in 2-4 weeks 1
  • Common side effects include gastrointestinal symptoms (nausea, constipation), dark stools, and teeth staining 1
  • Counsel on taking iron between meals for optimal absorption, though taking with food may improve tolerance 1

Second-Line: Intravenous Iron

Consider IV iron if any of the following apply:

  • Severe gastrointestinal side effects preventing oral iron adherence 3
  • Lack of hemoglobin improvement after 2-4 weeks of adequate oral iron therapy 3
  • History of gastrointestinal surgery affecting absorption 3
  • Hemoglobin remains critically low (<8.4 g/dL) requiring rapid correction 3

IV iron is safe and effective in pregnancy, increasing hemoglobin from approximately 8.4 to 10.1 g/dL by completion of therapy, with continued rise to 10.9 g/dL two weeks later 3. Calculate total iron dose based on hemoglobin level and patient weight 3.

Blood Transfusion Threshold

Reserve red blood cell transfusion for severe anemia with hemoglobin <6 g/dL, as this level is associated with adverse pregnancy outcomes including prematurity, spontaneous abortion, low birth weight, and fetal death 4.

Concurrent Supplementation

  • Add folic acid supplementation (or ensure prenatal vitamin contains adequate folate) to prevent folate deficiency megaloblastic anemia, which accounts for the remaining 25% of pregnancy anemias after iron deficiency 4
  • Consider multiple micronutrient supplementation as an alternative to isolated iron-folate 2

Monitoring Strategy

  • Recheck hemoglobin at 28 weeks gestation as recommended for routine anemia screening 2
  • Earlier reassessment (2-4 weeks) is warranted to confirm treatment response 1
  • Target hemoglobin ≥10 g/dL by third trimester, though ≥11 g/dL is optimal 4

Critical Considerations

Untreated moderate anemia (Hb 9.8 g/dL) increases maternal risk for postpartum hemorrhage, infections, preterm labor, and cardiac complications 5. Fetal risks include intrauterine growth restriction, preterm birth, and potential neurodevelopmental impairment 5.

The relationship between anemia and postpartum hemorrhage is bidirectional—anemia increases PPH risk while PPH worsens anemia—making correction before delivery essential 2.

Common pitfall: Prescribing only the 30 mg elemental iron found in standard prenatal vitamins, which is insufficient for treating established anemia 1. Treatment requires 60-120 mg daily 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

FIGO good practice recommendations on anemia in pregnancy, to reduce the incidence and impact of postpartum hemorrhage (PPH).

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025

Research

Anemia in pregnancy.

Annals of the New York Academy of Sciences, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.